Armando Philip S Paez MD FACP, FIDSA (He/Him)
HIV/AIDS Medicine, Healthcare Associated Infections
Chief of Division of Infectious Diseases, Director of Infectious Diseases Fellowship Program at Baystate Medical Center; Associate Professor, UMass Chan Medical School-Baystate
Join to View Full Profile
759 Chestnut StS4419Springfield, MA 01199
Phone+1 413-794-5376
Fax+1 413-794-4199
Dr. Paez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Armando Paez is an infectious disease specialist in Springfield, MA and is affiliated with multiple hospitals in the area, including Baystate Medical Center, Baystate Franklin Medical Center, and Baystate Noble Hospital. He received his medical degree from the University of Santo Tomas and has practiced for 17 years. He specializes in HIV/AIDS medicine, respiratory infections including COVID-19 and influenza, viral hepatitis, wound care, and medical education.
Education & Training
UMass Chan - BaystateFellowship, Infectious Disease, 2004 - 2006
Cleveland Clinic FoundationResidency, Internal Medicine, 2001 - 2004
University of Santo TomasClass of 1999
Certifications & Licensure
MA State Medical License 2004 - 2026
OH State Medical License 2001 - 2004
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Edward Kass Award for Clinical Excellence Massachusetts Infectious Disease Society, 2006
- Maxwell Finland Research Award Massachusetts Infectious Disease Society, 2006
- Magna Cum Laude University of Santo Tomas Faculty of Medicine and Surgery, 1999
- Join now to see all
Clinical Trials
- Respiratory Virus Hospitalization Study (FLU 003 Plus)
- Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study Start of enrollment: 2022 Dec 16
- COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1) Start of enrollment: 2020 Apr 03
- Join now to see all
Publications & Presentations
PubMed
- Breaking Barriers: A Single-Center Real-World Experience With Recruitment and Administration of COVID-19 Monoclonal Antibodies and Opportunities for Improvement.Sara Brenner, Alexander Knee, Douglas Salvador, Erica Housman, Gladys Fernandez
Open Forum Infectious Diseases. 2024-02-01 - 1 citationsChest wall abscess and costochondritis due to Salmonella enterica serotype Choleraesuis: a case report.Nassim R Mokraoui, Rose Ganim, Armando Paez
Journal of Medical Case Reports. 2023-12-06 - Monoclonal antibody infusion reaction with bamlanivimab and etesevimab in a 5-year-old male with coronavirus disease 2019: a case report.Rajapillai L I Pillai, Caroline Dziel, Stephanie Vogel, Frank Szczerba, Weijen W Chang
Journal of Medical Case Reports. 2023-02-24
Journal Articles
- Monoclonal antibody infusion reaction with bamlanivimab and etesevimab in a 5-year-old male with coronavirus disease 2019: a case report.1. Pillai RLI, Dziel C, Vogel S, Szczerba F, Chang WW, Camelo IY, Paez A, J Med Case Rep. 2023 Feb 24;17(1)
Press Mentions
What Changes with the End of COVID-19 Emergency?May 8th, 2023- New Covid-19 Subvariant Spreading Around the United StatesApril 26th, 2023
- New Subvariant of COVID-19 Seen in United StatesApril 24th, 2023
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Member
- Massachusetts Infectious Diseases SocietyPresident, Board of Directors
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
